The orphan GluD2 receptor belongs to the ionotropic glutamate receptor family but does not bind glutamate. Ligand-gated GluD2 currents have never been evidenced, and whether GluD2 operates as an ion channel has been a long-standing question. Here, we show that GluD2 gating is triggered by type 1 metabotropic glutamate receptors, both in a heterologous expression system and in Purkinje cells. Thus, GluD2 is not only an adhesion molecule at synapses but also works as a channel. This gating mechanism reveals new properties of glutamate receptors that emerge from their interaction and opens unexpected perspectives regarding synaptic transmission and plasticity.
Introduction
GluD2 is an ionotropic glutamate receptor (iGluR) family member [1] almost exclusively expressed by cerebellar Purkinje cells [2] . Its absence or mutation causes ataxia, deficits in motor learning [3] , and cognitive disorders in rodents [4] [5] [6] [7] . Its N-and C-terminal domains respectively control parallel fiber (PF) synapse development/maintenance and long-term depression (LTD) [3, [7] [8] [9] [10] . Evidence that the channel-pore of GluD2 is functional exists [1, 10, 11] , but this point is still debated since no gating ligand has ever been identified [12] . Interestingly, the subtype 1 metabotropic glutamate receptor (mGlu1) associates with GluD2 and transient receptor potential cation channel TRPC3 in Purkinje cells [13] . Moreover, some mGlu1-activated conductances share properties with GluD2 [14] . The occurrence of a functional crosstalk between mGlu1 and iGluRs [15] [16] [17] and the report of a mGlu1-mediated slow current carried by TRPCs [18] [19] [20] prompted us to investigate if a similar functional coupling occurs between mGlu1 and GluD2 receptors. Here we show that mGlu1 indeed triggers the opening of the GluD2 channel.
Results

mGlu1 triggers the opening of GluD2 channels in HEK293 cells
To examine the coupling between mGlu1 and GluD2 receptors, we first used HEK293 cells and the mGlu1alpha variant that we activated with 3,5-dihydroxyphenylglycine (DHPG, 100 lM). Membrane expression of the various constructs was verified (supplementary Figs S1-S3). In cells transfected with GluD2 or mGlu1 separately, DHPG did not induce any current (Fig 1A) . Conversely, in cells cotransfected with mGlu1 and GluD2 receptors, DHPG induced a slow inward current (81 AE 12 pA; n = 27, Fig 1A) . This current relied on GluD2 as DHPG elicited no current in cells co-transfected with mGlu1s and NMDA receptors (Fig 1A) . In cells co-expressing mGlu1 and GluD2, the current-voltage (I-V) relationship of the DHPGinduced current was similar to that of the constitutively opened Lurcher-or chimeric-GluD2s channels, with a characteristic inward rectification around + 20 mV [11, 21] (Fig 1B, n = 7) . Two inhibitors of GluD2, the calcium-permeable AMPA receptor (AMPA-R) blocker NASPM (100 lM) and D-serine (10 mM) [1, 11, 22, 23] , both reduced the slow DHPG-induced current (Fig 1C) , by 95 AE 8% (n = 7, P < 0.01) and by 64 AE 15% (n = 8, P < 0.02). On the contrary, the TRPC3 inhibitor Pyr3 did not change it (n = 5, P = 0.31, Fig 1C) . These data indicate that mGlu1 triggers GluD2 opening, resulting in a slow current with biophysical and pharmacological features typical of GluD2 currents.
To verify that it is carried by GluD2 but not by other conductances, we tested the mGlu1-mediated slow current in cells transfected with a dominant-negative GluD2 subunit. Introducing an arginine near the Q/R editing site of GluD2 disrupts the channel pore and turns it into a dominant-negative subunit as for AMPA/ KA-Rs [12, 24] . We generated the GluD2V617R subunits by replacing a valine at position 617 by an arginine in the GluD2 amino-acid sequence (Fig 1D) . DHPG elicited no current in cells transfected with mGlu1 and GluD2V617R (Fig 1D, n = 7) . Thus, this current requires functional GluD2 channels. In cells transfected with mGlu1, wild-type (WT) GluD2 and GluD2V617R, the DHPG current decreased as the quantity of GluD2V617R plasmids co-transfected increases (Fig 1E and F) . It was almost abolished when WT and dominant-negative GluD2s were transfected in equal proportions (Fig 1E and F) . Thus, GluD2 channels themselves carry the slow current triggered by mGlu1s. This supports the view that they are functional [5, 25] , and designates mGlu1 as their physiological activator.
mGlu1 triggers GluD2 opening in native conditions
In cerebellar Purkinje cells, repetitive stimulations of PFs induce a mGlu1-mediated slow excitatory post-synaptic current (PF-slow EPSC) carried by several conductances, notably TRPC3s [18-20]. As mGlu1s, TRPC3s and GluD2s associate and regulate the mGlu1-dependent current at PF-Purkinje cell synapses [13, 26, A DHPG induced current at À60 mV in cells expressing mGlu1, GluD2 or NR1-NR2B subunits, alone or in combination. B The I-V relationship of the DHPG current in a cell expressing mGlu1 and GluD2. C NASPM, D-serine but not Pyr3 inhibit the DHPG current in cells transfected with GluD2 and mGlu1. D The GluD2V617R dominant-negative construct (top, S1, S2: LBD). Lack of DHPG current in cells expressing mGlu1 and GluD2V617R (bottom). E GluD2V617R reduces the DHPG current. Representative traces from cells transfected with mGlu1 and GluD2 together with increasing amounts of GluD2V617R plasmid (green arrow). 27], we tested whether GluD2 pore contributes to the mGlu1-dependent PF-slow EPSC. We induced this slow mGlu1-mediated EPSC with 8 pulses of 100 Hz PF-stimulation (Fig 2A) , in the presence of GABA-A, AMPA and NMDA receptor inhibitors (bicuculline, NBQX, D-APV, resp. 20, 10, 50 lM). Its intensity was 281 AE 26 pA (n = 46, Fig 2B) , and it was blocked by the mGluR1/5 antagonist AIDA (150 lM, supplementary Fig S4A) . As expected [18] [19] [20] , it was reduced by 35 AE 9% by the TRPC3s inhibitor Pyr3 (10 lM, n = 8, P < 0.01). The GluD2 blocker NASPM (100 lM) further decreased it to 78.3 AE 3% of the control (Fig 2B) . D-serine (10 mM) also reduced this slow current by 58.5 AE 4.3% when considering its NASPM-sensitive fraction (n = 7, Fig 2C) . Thus, GluD2 channels likely contribute to the mGlu1-dependent slow EPSC in Purkinje cells. If so, the dominant-negative GluD2V617R mutant should reduce it. To test this, we transduced cerebella of WT mice with recombinant Sindbis virus carrying the sequences of GluD2V617R and the marker green fluorescent protein (GFP) (Fig 2D) . In all the Purkinje cells expressing GluD2V617R tested, the PF-slow EPSC was reduced (87 AE 36 pA, n = 8, Fig 2E) as compared to cells transfected with GFP only (265 AE 23 pA, n = 5; P < 0.01, Fig 2E) or to those not transfected (281 AE 26 pA; n = 46; P < 0.01). In the GFP alone condition, the averaged trace displayed slower kinetics, two of the five cells recorded here having slow mGlu1 currents. However, this could not be attributed to the presence of GFP, but simply reflected a cell-to-cell variability that we observed in all the experiments of the study (see another example in supplementary Fig S4A) , whatever the genotype or manipulation. In our hands, a quarter of the Purkinje cells had such slow kinetics, however we can provide any explanation for this.
Thus, altogether, both pharmacological blockade and genetic disruption of GluD2 channel pore decrease the mGlu1-dependent slow EPSC, indicating that mGlu1s trigger GluD2s gating in native conditions.
The PF-slow EPSC is reduced in mutant mice lacking GluD2 channels Mice from the Hotfoot (HO) family bear deletions in the GluD2 encoding gene Grid2. The HO-Nancy GluD2 proteins lack their channel and ligand-binding domain (LBD) ( [6, 28] , Fig 3A) , providing a model to test mGlu1 currents in the absence of GluD2 pore. Immunohistochemistry in WT mice confirmed that GluD2s locate in thin dendrites of Purkinje cells ( [7] , Fig 3B) . In HO-Nancy, although a fraction of GluD2 proteins remained trapped at the level of Purkinje cells somata (Fig 3B) , their dendrites, including proximal ones, were also labeled, supporting the previous observation that HO-Nancy GluD2s reach the membrane [8] . An anti-GluD1/2 antibody gave similar results (supplementary Fig S5) . Then, we quantified the mGluR1-mediated PF-slow EPSC in HO-Nancy Purkinje cells using calibrated PFs stimulation to compare with WT (see supplementary Fig S4B-C) . Half of the HO-Nancy cells display no PF-slow EPSC (n = 19/37, Fig 3C , left trace on right panel, versus n = 4/72 in WT). In the 18 others, a small slow EPSC was recorded (71 AE 18 pA), which was blocked by AIDA (Fig 3C, right trace on right panel). In the HO-4j mice, extrasynaptic mGlu1 currents were shown to increase [13] . To record both synaptic and extrasynaptic mGlu1-currents, we used bath applications of DHPG (50 lM, 30 s) in the presence of TTX, NBQX, D-APV and bicuculline (resp. 1, 10, 50, 20 lM). The DHPG current was detectable in all the HO-Nancy Visou
Purkinje cells but was smaller than in WT cells, (respectively 234 AE 60 pA, n = 13 versus 773 pA AE 136 pA, n = 9, P < 0.01; Fig 3D) . Thus, in Ho-Nancy Purkinje cells, mGlu1 currents are smaller than in WT cells, the reduction being more pronounced at synapses than outside. Importantly, this does not result from a reduced number of mGlu1s at the membrane since their amount does not change in the absence of GluD2 [3, 13] . Together, these data suggest that GluD2 channels participate to the mGlu1-activated currents in Purkinje cells, and support our previous conclusion that GluD2 gating is triggered by mGlu1s.
Discussion
Here, we demonstrate that mGlu1s activation triggers a current carried by GluD2 channels, showing for the first time that WT GluD2 have an ionotropic nature and that their gating can be, at least indirectly, triggered by glutamate.
An important consequence of this coupling is that GluD2s as well as TRPCs contribute to the mGlu1-activated currents in Purkinje cells [29, 30] . This unexpected finding may explain why several previous studies disagreed on the nature of mGlu1 currents, or more recently, on the effects of TRPCs inhibitors on them [14, [31] [32] [33] . The respective contribution of TRPC1/3 and GluD2 may depend on the experimental conditions and/or on the splicing variants of mGlu1, as these latter vary among cerebellar regions [34] . These conditions remain to be clarified.
The presence of the dominant-negative or the HO-Nancy GluD2s could have changed the number of mGlu1s or TRPC3 [13, 35] thereby explaining the decrease of the mGlu1 current. This is very unlikely. GluD2s do not seem to behave as scaffold or auxiliary proteins [3, 13] . Moreover, the existence of a GluD2-dependent mGlu1 current in HEK293 cells that is inhibited by D-serine, NAS-PM and GluD2V617R but not Pyr3 shows that the mGlu1 current flows through GluD2s, and not through some other interacting channel. 
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Even if the coupling between mGlu1 and GluD2 is reminiscent of other metabotropic-ionotropic receptor crosstalks [15, 36] , it appears unique in that mGlu1 triggers, rather than modulates, the gating of GluD2. However, none of our data suggest that it involves a direct activation of GluD2 by mGlu1. Intermediate steps cannot be excluded. Remarkably, the GluD2s gating mechanism supports the view that their LBD works differently from that of other iGluRs [11, 22, 25] . It also makes glutamate their indirect activator, which eventually brings these orphans back to their original family of ionotropic glutamate receptors. As such, GluD2s have some permeation, regulation and trafficking properties of AMPA/KA-R, but they also require mGlu1 for their activation. Thus, GluD2 currents display chimeric properties that derive from both mGlu1 and AMPA/KA-Rs.
Some of our results seem to contradict previous ones showing no reduction of mGlu1 currents and a redistribution of mGlu1s and TRPC3s in the absence of GluD2 [13] . However, these studies have been made in HO-4j mice, where truncated GluD2s are retained in the endoplasmic reticulum, which is not the case for HO-Nancy. Thus, the two models are different.
Some studies question the ionotropic nature of GluD2, based on the fact that PF LTD and the establishment of normal climbing fiber connection do not to depend on GluD2 channels [12, 37] . However, this is not enough to refute the existence of GluD2 currents. Such currents could be necessary for other aspects of cerebellar physiology. As GluD2s are much less permeable to calcium than TRPC3 [21, 38] , the GluD2/TRPC3 ratio could set the permeability of the mGlu1 conductance to calcium which could, for example, determine the polarity (LTP/LTD) of synaptic plasticity.
In contrast to conventional fast AMPA-Rs, the mGlu1/GluD2 duo converts high frequency input into a slow current. This duo is expressed in the vast majority of PF synapses [27] whereas more than 80% of these synapses are silent [39] , and thus have no or few AMPA-Rs. This suggests that most PF synapses act as a highpass filter and that Purkinje cells relay high versus low frequency PF inputs with very different dynamics.
The other delta family member GluD1 has 60% sequence homology with GluD2 [40] and is similarly endowed with a functional channel pore domain [25, 41] . We suggest that GluD1 might also be activated by metabotropic receptors, which would provide synapses with differential dynamical response to low and high frequency inputs.
Finally, the metabotropic-dependent gating of GluDelta receptors enriches the computational repertoire of synapses. It makes these former orphans prodigal children of the glutamate receptor family.
Materials and Methods
Plasmids and virus production
The plasmids encoding mGlu1a and NR1A/NR2B subunits under the control of a cytomegalovirus promoter, have been described previously (pRK5-HA-mGlu1a [15, 42] ). GluD2 coding sequence, obtained by PCR from cerebellar cDNA, was amplified and assembled in pcDNA3.0 (Invitrogen, Carlsbad, CA, USA). The V617R mutation was verified with sequencing. For Sindbis virus production, WT and mutant coding sequences of GluD2 were amplified using Phusion high-fidelity DNA polymerase (Finnzyme, Vantaa, Finland) and inserted in pSinEGdsp [43] . Two distinct promoters upstream GluD2 and GFP sequences allowed the 2 proteins to express separately [43] . Recombinant viruses were produced as described in [44] .
HEK293 cell culture and transfection HEK293 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/ml penicillin and streptomycin, 2 mM L-glutamine (all from Wisent, St Bruno, Canada). Transient transfections were performed using calcium phosphate precipitation method [15] on cells seeded at a density of 2 9 10 6 cells per 100 mm dish and cultured for 24 h.
DMEM was renewed 24 h after transfection and cells cultured for an additional 24 h.
Animals
Animal breeding and euthanasia were performed in accordance to European and French legislation (NOR ATEN0090478A, code rural art. 276). HO-Nancy mice were raised in the lab [28, 45] . WT mice came from Janvier Laboratory (Le Genest-St-Isle, France). All had C57BL/6 background.
Electrophysiology
Solutions are detailed in supplementary methods. Whole-cell voltage-clamp recordings of HEK293 cells were made at room temperature using 3-5 Ω pipettes filled with a cesium chloride-based solution (20 mM EGTA). Cells were superfused with a HEPES buffered solution containing 10 mM glycine and 300 nM tetrodotoxin (TTX). Currents were recorded with an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA, USA), filtered at 1 kHz, digitized at 3 kHz and analyzed with the pClamp 9 software (Molecular Devices). Patch-clamped recordings of Purkinje cells were made in wholecell at À70 mV or in current-clamp (supplementary information and [46] ). The C57BL/6 mice were 2-6 months old. Recording pipettes (2-4 MΩ) contained a K-gluconate (144 mM)/KCl (6 mM) based internal solution (1 mM EGTA). Liquid junction potentials were not corrected. We used Axopatch-200A and Multiclamp 700B (Molecular Devices) amplifiers and ACQUIS1 (Bio Logic, Claix, France), P-Clamp9 (Molecular Devices) and Igor Pro 6.1 (WaveMetrics, Lake Oswego, OR, USA) softwares for acquisition and analysis. Drugs came from Sigma-Aldrich (Saint-Quentin Fallavier, France) except NBQX, D-APV, DHPG and AIDA that came from Tocris Cookson and R&D Systems (Lille, France).
Immunohistochemistry
Mice under deep pentobarbital anesthesia were fixed transcardially with 4% PFA in phosphate-buffered saline. Primary antibodies (dilution; provider; ref.) used: anti-calbindin (CALB1, 1/5000; Swant, Marly, Switzerland, 300), anti-GluD1/2 (1/150; Millipore, Billerica, Maryland, USA, AB1514) and anti-GluD2 (1/200; Frontier Institute, Hokkaido, Japan; GluRd2C-Rb-Af500). They were incubated with 60 lm thick free-floating cerebellar slices overnight. Secondary antibodies were AlexaFluor -488 and -546 (Invitrogen). Confocal images were acquired with a Leica SP5 confocal microscope and processed with the ImageJ software (http://rsbweb.nih. gov/ij/).
Virus injection
Two-month-old C57BL/6 male mice were anesthetized with ketamine and xylazine, then placed on a Kopf stereotaxic apparatus (Harvard Apparatus, Les Ulis, France). Viruses were injected (one injection, 2 ll, over 8 min) in lobule VI of the vermis. Three animals received the virus carrying GluD2V617R + GFP and 3 received the control virus carrying GFP alone. Electrophysiological studies were performed 24 or 48 h later.
Statistical analysis
Data are provided as the mean currents peak amplitude AE s.e.m. calculated for n different cells, details available in supplementary methods. We used Mann-Whitney or Wilcoxon tests, respectively for unpaired and paired groups. The P value is the probability of the null hypothesis. 
